These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38014768)

  • 1. HIV disease metrics and COVID-19 infection severity and outcomes in people living with HIV in central and eastern Europe.
    Oprea C; Quirke S; Ianache I; Bursa D; Antoniak S; Bogdanic N; Vassilenko AI; Aimla K; Matulionyte R; Rukhadze N; Harxhi A; Fleischhans L; Lakatos B; Sedlacek D; Dragovic G; Verhaz A; Yancheva N; Acet O; Protopapas K; Kowalska JD;
    HIV Med; 2024 Mar; 25(3):343-352. PubMed ID: 38014768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    Chang JJ; Bruxvoort K; Chen LH; Akhavan B; Rodriguez J; Hechter RC
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):1-5. PubMed ID: 34397741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group.
    Kowalska JD; Bieńkowski C; Fleischhans L; Antoniak S; Skrzat-Klapaczyńska A; Suchacz M; Bogdanic N; Gokengin D; Oprea C; Karpov I; Kase K; Matulionyte R; Papadopoulos A; Rukhadze N; Harxhi A; Jilich D; Lakatos B; Sedlacek D; Dragovic G; Vasylyev M; Verhaz A; Yancheva N; Begovac J; Horban A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    Patel VV; Felsen UR; Fisher M; Fazzari MJ; Ginsberg MS; Beil R; Akiyama MJ; Anastos K; Hanna DB
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):224-230. PubMed ID: 33433966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
    Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Virologic and Immunologic Outcomes for HIV Patients With Coronavirus Disease 2019.
    Hu R; Yan H; Liu M; Tang L; Kong W; Zhu Z; Liu P; Bai W; Hu X; Ding J; Wang X; Xie N
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):213-218. PubMed ID: 33079905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
    Fursa O; Bannister W; Neesgaard B; Podlekareva D; Kowalska J; Benfield T; Gerstoft J; Reekie J; Rasmussen LD; Aho I; Guaraldi G; Staub T; Miro JM; Laporte JM; Elbirt D; Trofimova T; Sedlacek D; Matulionyte R; Oprea C; Bernasconi E; Hadžiosmanović V; Mocroft A; Peters L;
    HIV Med; 2024 Jun; 25(6):711-724. PubMed ID: 38433476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.
    Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E; de la Mora L; Martinez-Rebollar M; Laguno M; Callau P; Gonzalez-Navarro A; Leal L; Garcia F; Mallolas J; Mosquera M; Marcos MA; Ambrosioni J; Miro JM; Martinez E; Blanco JL;
    AIDS; 2020 Oct; 34(12):1775-1780. PubMed ID: 32773471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.
    González Guembe M; Tisner Pensado Y; Tejerina Picado F; Diez C; Pérez Latorre L; Fanciulli C; Parras Vázquez F; López Bernaldo de Quirós JC; Berenguer J; Padilla Ortega B; Machado M; Valerio Minero M; Muñoz Garcia P; Bouza Santiago E; Galar A; Catalan P; Alonso R; Bellón JM; Aldámiz-Echevarría Lois T;
    AIDS Res Hum Retroviruses; 2022 May; 38(5):394-398. PubMed ID: 34969259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
    Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
    J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    Nasreddine R; Florence E; Moutschen M; Yombi JC; Goffard JC; Derdelinckx I; Lacor P; Vandekerckhove L; Messiaen P; Vandecasteele S; Delforge M; De Wit S;
    J Med Virol; 2021 May; 93(5):2971-2978. PubMed ID: 33506953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
    PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection.
    Madge S; Barber TJ; Hunter A; Bhagani S; Lipman M; Burns F
    Sex Transm Infect; 2021 Aug; 97(5):392-393. PubMed ID: 32879027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.
    Ceballos ME; Ross P; Lasso M; Dominguez I; Puente M; Valenzuela P; Enberg M; Serri M; Muñoz R; Pinos Y; Silva M; Noguera M; Dominguez A; Zamora F;
    Int J STD AIDS; 2021 Apr; 32(5):435-443. PubMed ID: 33533294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.
    Kowalska JD; Kase K; Vassilenko A; Harxhi A; Lakatos B; Lukić GD; Verhaz A; Yancheva N; Dumitrescu F; Jilich D; Machala L; Skrzat-Klapaczyńska A; Matulionyte R
    Int J Infect Dis; 2021 Mar; 104():293-296. PubMed ID: 33326871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving force of COVID-19 among people living with HIV in Wuhan, China.
    Guo W; Ming F; Dong Y; Zhang Q; Liu L; Gao M; Zhang X; Mo P; Feng Y; Tang W; Liang K
    AIDS Care; 2022 Nov; 34(11):1364-1371. PubMed ID: 35319336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.